Tokyo, Japan

Takeo Koyama

This inventor holds 4 USPTO granted patents. Top assignees: Daiichi Pharmaceutical Co., Ltd., Aruze Corporation. Active years: 2001-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takeo Koyama. Retrieved from https://idiyas.com/inventor/takeo-koyama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 75.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2001-2003

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Takeo Koyama: Innovator in Pharmaceutical Chemistry

Introduction

Takeo Koyama is a distinguished inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work has had a notable impact on the development of various chemical compounds.

Latest Patents

Among his latest patents is the "Process for preparing 2-phenyl-3-naphthylpropionic acid derivatives." This innovative process showcases his expertise in synthesizing complex chemical structures that are essential in pharmaceutical applications.

Career Highlights

Throughout his career, Takeo Koyama has worked with prominent companies such as Daiichi Pharmaceutical Co., Ltd. and Aruze Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Takeo has collaborated with notable colleagues, including Yukio Yokoyama and Tatsuya Kobayashi. These partnerships have fostered a creative environment that has led to the advancement of various projects and innovations.

Conclusion

Takeo Koyama's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence the development of new chemical processes and compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…